MIMS supplement on contraception and HRT

The December issue of MIMS includes a special supplement on women's health. Download a digital version here (GPs/nurses/subscribers only).

A special supplement on contraception and HRT has been published with the December 2019 issue of MIMS.

National statistics data from 2017/18 for England indicate that most of the women who attended sexual and reproductive health services for contraception were using hormonal contraceptives, with 42% using oral contraceptives and 41% using long-acting reversible contraceptives (LARCs).

Approximately a million women in the UK take HRT for menopausal symptoms. In England and Wales £57.2 million is spent every year on HRT and topical oestrogen. In 2013, approximately 85% of HRT used was oral and 15% was transdermal – however, the percentage of women using transdermal HRT was predicted to increase after publication of the NICE menopause guidance in 2015.

The MIMS supplement covers:

  • Overview of the menstrual cycle and menopause
  • Factors affecting contraceptive choice
  • Diagnosis of menopause
  • Use of HRT

The supplement is worth 1 CPD credit towards appraisal and revalidation. Claim your printed copy with the December issue of MIMS or download a digital version below. 

Download supplement

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

An elderly woman with one arm in a plaster cast sits resting both hands on her walker

Doctors urge NICE to reverse decision on new osteoporosis drug

More than NHS 100 clinicians have called on NICE to...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Image of both strengths of Seffalair Spiromax inhaler side by side.

New salmeterol/fluticasone dry powder inhaler for asthma

Seffalair Spiromax is the sixth dry powder salmeterol/fluticasone...

An older man in a blue shirt and beige trousers leans forward on a sofa rubbing his painful lower back. Promoted

Established muscle relaxant offers new approach to managing back pain

Sponsored by Mibe Pharma

A muscle relaxant that has been used for decades outside the UK may provide an alternative to current treatments for low back pain, explains Dr Sunny Nayee, consultant in anaesthesia and pain medicine at Imperial College NHS Healthcare Trust.

Sponsored by Mibe Pharma UK Ltd. UK/MYO/21/044; December 2021.

Click here to view prescribing information for Myopridin® (pridinol mesilate)